when did Greece increase pharma rebate 16.7 to 21.7

The 16.7% to 21.7% increase appears to have been part of Greece’s pharma rebate/clawback escalation around the early 2020s, but the material I found does not show a single exact date for that specific jump.

What I can verify is this:

• Greece’s mandatory rebate/clawback framework was already in place by 2012.

• Later industry coverage describes an “additional 2–21 percent” rebate layer depending on product type and spending volume.

• A 2018 source also refers to a 17% average claw-back alongside other rebates, showing the rate was already moving in that period.

Best answer

If you are asking about the specific point when the rebate moved from 16.7% to 21.7%, I can’t confirm that exact change date from the sources available here.

What likely happened

That kind of figure usually comes from a category-specific adjustment or a later ministerial update, not a single headline reform. The public sources I found mention the broader rebate system and its increases, but not the exact “16.7 to 21.7” transition date.

Useful takeaway

• The Greek pharma rebate/clawback system was introduced as a crisis-era cost-containment measure.

• Rates and formulas have been revised multiple times since then.

• The exact jump you asked about needs a specific legal text or ministry decision to pin down.

TL;DR: I could verify that Greece’s pharma rebate system has been in place since 2012 and has been revised repeatedly, but I could not verify the exact date of the 16.7% to 21.7% increase from the available sources.